Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arthropod gamma-aminobutyric acid (GABA)-gated chloride channels are essential inhibitory neurotransmitter receptors in the central nervous system of insects and other arthropods (Sattelle et al., 1991). These receptors belong to the Cys-loop superfamily of ligand-gated ion channels and are typically composed of five subunits, most notably the Resistance to dieldrin (RDL) subunit, which form a chloride-selective pore (UniProt Consortium, 2024). Upon binding of GABA, the channel opens to allow chloride influx, leading to hyperpolarization and inhibition of neuronal activity. These channels are the primary targets for several major classes of insecticides, including phenylpyrazoles like fipronil and the newer isoxazolines like fluralaner (Gassel et al., 2014). These compounds typically act as non-competitive antagonists, binding within the channel pore to block chloride conductance, which causes over-excitation of the nervous system, paralysis, and death (Casida & Durkin, 2013). Because arthropod GABA receptors exhibit distinct pharmacological profiles compared to their mammalian counterparts, they provide a high degree of selective toxicity, making them ideal targets for pest control and veterinary medicine (IRAC, 2023).
Non-competitive antagonism of the chloride channel pore, leading to hyperexcitation of the nervous system and death of the arthropod (Casida & Durkin, 2013).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arthropod gamma-aminobutyric acid-gated chloride channel (GABA-Cl).